Method for detecting porcine circovirus Cap protein VLP assembly rate and content
Detection of VLP assembly rate and content of pig cyclovirus Cap protein by high-performance liquid phase volume exclusion chromatography, solving the problem that cannot be accurately detected in the existing technology, and achieving efficient and accurate quality control of pig cyclovirus vaccines and Finished product evaluation.
Patent Information
- Application Number
- CN202411200820.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-29
- Publication Date
- 2024-12-06
AI Technical Summary
现有的方法无法精准定量检测猪圆环病毒Cap蛋白的含量和VLP的组装率,无法有效判断蛋白的纯度和组装情况,影响疫苗的质量控制和免疫效果。
Using high-performance liquid phase volume exclusion chromatography, the assembly rate and content of VLP were calculated by establishing standard curves and detecting peak areas, combined with western blot Identification with electron microscopy method.
The accurate quantitative and assembly rate detection of the pig cyclovirus Cap protein VLP is achieved, with efficient, accurate and simple operation, suitable for vaccine production and quality evaluation, and improves the quality control of vaccines and the accuracy of finished product evaluation.
Smart Images

Figure CN119086747A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology and relates to a method for detecting the assembly rate and content of porcine circovirus Cap protein VLP. Background Art
[0002] Porcine circovirus (PCV) is a pathogen that causes a variety of porcine circovirus-associated diseases (PCVAD). Its infection causes suppression of the immune system function of pigs, and secondary infections with other pathogens such as bacteria, which seriously affects the health of pigs and causes huge economic losses worldwide. PCV belongs to the Circoviridae family and the Circovirus genus. Based on the differences in PCV genome sequence and antigenic characteristics, it is currently divided into four genotypes: PCV1, PCV2, PCV3 and PCV4. The PCV genome is a single-stranded closed circular DNA containing two open reading frames, ORF1 and ORF2. The viral capsid protein (Cap), encoded by ORF2, is the only structural protein of PCV. Cap contains multiple neutralizing antigenic epitopes that can stimulate the body to produce persistent humoral immunity and cellular immunity. It is a key antigen for PCV to induce host immune response, so Cap is a key target protein in the study of PCV genetic engineering vaccines.
[0003] Virus-like particles (VLPs) are hollow particles that do not contain genetic material and are self-assembled from viral structural proteins. They have no ability to replicate or infect. Their structure is similar to that of natural viruses, making them more easily engulfed, processed, and presented by antigen-presenting cells, and they have high immunogenicity. PCV VLPs are composed of 12 Cap pentamers and a total of 60 Cap protein monomers.
[0004] At present, vaccination is the best means of preventing and controlling PCV infection in pig farms, and recombinant subunit vaccines are playing an increasingly critical role. At present, domestic vaccine manufacturers mainly express the Cap protein of PCV2 through recombinant baculovirus expression systems and Escherichia coli expression systems. The expressed Cap protein can assemble into VLPs by itself, forming an icosahedral shape similar to the natural PCV2 virus. However, there are differences in the expression amount of proteins under different expression systems, and there are also differences in the efficiency of monomeric protein assembly into VLPs. According to literature reports, the immunogenicity of PCV Cap protein forming VLP is significantly better than that of monomeric Cap protein.
[0005] The most core quality control items for PCV subunit vaccines are protein content, purity and VLP assembly rate, which are crucial to the immune effect and safety of the vaccine.
[0006] At present, the methods for determining protein content mainly include ultraviolet spectrophotometry, 2,2'-biquinoline-4,4'-dicarboxylic acid method (BCA), Coomassie brilliant blue method (Bradford) and SDS-PAGE method. The first three methods cannot specifically quantify the target protein, and the total protein is detected, and the purity of the protein cannot be determined. The SDS-PAGE method can specifically detect the protein, but it can only be semi-quantitative. Moreover, none of the above four methods can detect the VLP assembly rate. Therefore, there is an urgent need for a detection method to accurately quantify the content of PCV Cap protein and detect the assembly of VLP.
[0007] High performance liquid size exclusion chromatography (HPSEC) is a chromatographic technique that separates and detects samples based on their molecular size. Large molecules are eluted before small molecules, and the target protein can be determined based on the peak time. It has the advantages of being fast, accurate, and efficient. The HPSEC method is widely used in the field of vaccine purity analysis and detection, such as diphtheria, pertussis, and tetanus combined vaccines, hepatitis E vaccines, enterovirus 71 vaccines, influenza vaccines, rabies vaccines, etc. The "Recombinant Hepatitis B Vaccine (CHO Cells)" in Part III of the "Chinese Pharmacopoeia" (2020 edition) stipulates that the HPSEC method shall be used for purity testing, but there are no relevant regulations for the purity determination method of porcine circovirus (PCV) vaccines. Summary of the invention
[0008] The purpose of the present invention is to provide a method for detecting the VLP assembly rate and content of porcine circovirus Cap protein. Compared with conventional methods, the present invention can not only detect the concentration of porcine circovirus Cap protein, but also detect the VLP assembly efficiency. The detection is convenient, efficient, fast and accurate, and is suitable for porcine circovirus vaccine antigen production and quality evaluation.
[0009] The present invention provides a method for detecting the assembly rate and content of porcine circovirus Cap protein VLP, which adopts a high performance liquid phase size exclusion chromatography detection method, and the chromatographic conditions include:
[0010] Chromatographic column: TSK-gel G6000PWXL;
[0011] Detection wavelength: 280nm;
[0012] Mobile phase: The mobile phase composition is 50 mM phosphate buffer and 100 mM sodium sulfate, pH 7.0-7.2.
[0013] This method can detect the proportion and content of VLPs in the sample to be tested, and includes the following steps:
[0014] (1) Establishing a high performance liquid phase size exclusion chromatography detection method, determining the detection conditions, and obtaining the target porcine circovirus Cap protein VLP chromatographic peak area and porcine circovirus Cap protein monomer peak area in the reference product through the detection method;
[0015] (2) Establish a standard curve of the linear relationship between the specific absorption peak area of porcine circovirus Cap protein and protein concentration;
[0016] (3) Detecting the sample by the high performance liquid phase size exclusion chromatography method of step (1), obtaining the specific absorption peak area of the porcine circovirus Cap protein VLP form and the porcine circovirus Cap protein monomer absorption peak area of the sample, substituting the sum of the two absorption peak areas, i.e., the specific absorption peak area of the porcine circovirus Cap protein, into the standard curve of step (2), and calculating the total concentration of the porcine circovirus Cap protein of the sample;
[0017] (4) Calculate the VLP assembly rate by the ratio of the peak area of the porcine circovirus Cap protein VLP obtained in step (3) to the total peak area of the Cap protein, and calculate the VLP content by multiplying the total Cap protein concentration by the VLP assembly rate.
[0018] Furthermore, in the step (1), a mobile phase was used to balance the baseline before sample injection, the mobile phase flow rate was 0.6 ml / min, the sample injection volume was 10 μL, the detector was an ultraviolet detector, the detection wavelength was 280 nm, the column temperature was 25° C., and the recording time was 30 min.
[0019] Furthermore, the detection method in step (1) further comprises collecting the main peak and the secondary peak using a fraction collector, and concentrating the collected samples using a 10KDa ultrafiltration concentrator.
[0020] Furthermore, the detection method in step (1) also includes using western blot and electron microscopy methods to identify the samples collected and concentrated in step (1).
[0021] Furthermore, in the high performance liquid size exclusion chromatography detection method used in the steps (1), (2), (3) and (4), the chromatographic column used is TSK-gel G6000PWXL; in the high performance liquid size exclusion chromatography method in the steps (1), (2), (3) and (4), the mobile phase needs to be filtered through a filter with a pore size of 0.22 μm and ultrasonically treated before use.
[0022] Furthermore, in step (2), a linear regression equation was established with the standard protein concentration as the ordinate and the peak area as the abscissa, and the linear relationship was y=0.1136x-22.917, and its R 2 is 0.9998.
[0023] Furthermore, the concentration of the porcine circovirus Cap protein in the linear regression equation ranges from 175 μg / mL to 2800 μg / mL.
[0024] The beneficial effects of the present invention are as follows: the specific high performance liquid phase size exclusion chromatography (HPSEC) established by the present invention can significantly distinguish the VLP form and the monomer form of the porcine circovirus Cap protein, has specificity and applicability, and can calculate the assembly rate of porcine circovirus VLP according to the ratio of the VLP peak area to all peak areas. In addition, a standard curve is established by the concentration and peak area of the standard to accurately quantify the content of the sample. Compared with conventional methods, this method is simple to operate, has good repeatability, and strong specificity, and can distinguish the VLP form and the monomer form of the porcine circovirus Cap protein. The present invention has great application value in the quality control of the porcine circovirus vaccine production process and the quality evaluation of the finished vaccine. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] In order to more clearly illustrate the specific implementation mode of the present invention, the present invention will be further described below in conjunction with the accompanying drawings and embodiments.
[0026] Figure 1 The chromatographic analysis pattern of the porcine circovirus Cap protein detected by the high performance liquid phase size exclusion chromatography method in Example 1;
[0027] Figure 2 Western blot test results of the main peak and the secondary peak were collected by the high performance liquid size exclusion chromatography method in Example 1;
[0028] Figure 3 The transmission electron microscopy results of the main peak and the secondary peak were collected by the high performance liquid size exclusion chromatography method in Example 1;
[0029] Figure 4 The standard curve established in Example 2 based on the protein concentration and peak area of the porcine circovirus Cap protein standard at different dilutions;
[0030] Figure 5 This is the chromatographic analysis graph of the four porcine circovirus vaccine products in Example 3. DETAILED DESCRIPTION
[0031] The present invention is further described below with reference to the examples, but is not intended to limit the scope of the present invention. The instruments, reagents, etc. used in the examples, unless otherwise specified, are conventional instruments and reagents available in the prior art and can be obtained through commercial channels.
[0032] High performance liquid size exclusion chromatography is a chromatographic technique that separates and detects samples based on their molecular size. Large molecules are eluted before small molecules, and the target protein can be determined based on the peak time. Porcine circovirus Cap protein VLP is composed of 60 Cap protein monomers, which form virus-like particles (VLPs) with a diameter of 17 to 20 nm. The VLP form is larger than the monomer form, so in theory the VLP form is eluted before the monomer form, allowing separation and detection.
[0033] Main reagents and instruments: phosphate buffer (disodium hydrogen phosphate, sodium dihydrogen phosphate) and sodium sulfate were purchased from Sinopharm Chemical Reagent Priority Company, Waters Arc high performance liquid chromatograph was purchased from Waters Corporation of the United States, and TSK-gelG6000PWXL chromatographic column (7.8mm*30cm, 13μm) was purchased from TOSOH Company of Japan.
[0034] The porcine circovirus type 2 Cap protein expressed by the recombinant baculovirus used in the present invention is prepared by Keqian Biotechnology Co., Ltd., as disclosed in patent CN113058032B.
[0035] Example 1: Identification of VLP and monomeric forms of porcine circovirus Cap protein.
[0036] Establishment of High Performance Liquid Chromatography (HPLC):
[0037] Testing conditions:
[0038] A TSK-gel G6000PWXL chromatographic column (7.8 mm*30 cm, 13 μm) was used, and the filler was a hydrophilic vinyl polymer.
[0039] The mobile phase composition was 50 mM phosphate buffer and 100 mM sodium sulfate, pH 7.0-7.2;
[0040] Before sample injection, the mobile phase was used to balance the baseline, the mobile phase flow rate was 0.6 ml / min, and the sample injection volume was 10 μL;
[0041] The detection wavelength was 280 nm, the column temperature was 25 °C, and the recording time was 30 min.
[0042] Using the above conditions, the porcine circovirus type 2 Cap protein (reference) expressed by baculovirus in 50 mM phosphate buffer and 100 mM sodium sulfate, pH 7.0-7.2 (blank solvent) was detected.
[0043] The blank solvent should have no absorption peak within the target protein peak range. Figure 1 As shown, a main peak appears at 16.9 minutes and a secondary peak appears at 20.1 minutes. During the detection, the main peak and the secondary peak were repeatedly sampled and collected using a fraction collector. The collected samples were concentrated by a 10KDa ultrafiltration concentrator, and the concentrated samples were detected by western blot and transmission electron microscopy.
[0044] like Figure 2 As shown, using porcine circovirus type 2 Cap protein-specific monoclonal antibody detection, the main peak and the secondary peak both have obvious bands around 30Kda, proving that the main peak and the secondary peak are the target peaks of the Cap protein. Figure 3 As shown, transmission electron microscopy observed that there were obvious VLPs in the main peak sample, which were about 20nm in size, consistent with the size of the Cap protein, while no VLPs were observed in the secondary peak sample. Because the VLP form is larger than the monomer form and will elute earlier than the monomer form, it can be determined that the main peak is the Cap protein VLP peak and the secondary peak is the Cap protein monomer peak.
[0045] This shows that the detection method established in this example has good applicability and specificity.
[0046] Example 2
[0047] The mobile phase is crucial to the detection results. The peak shape, peak area and peak height of the protein are different under different mobile phases. In order to screen the most suitable mobile phase, the phosphate buffer (PB) and sodium sulfate in Example 1 were preset to 0mM, 50mM, 100mM, and 200mM, respectively. The orthogonal method was used to explore the most suitable mobile phase concentration. A total of 15 mobile phases were configured to detect the peak shape, peak area and peak height of porcine circovirus Cap protein under each mobile phase.
[0048] The results are shown in Table 1. When the mobile phase composition is 50 mM PB and 100 mM sodium sulfate, the porcine circovirus Cap peak area and main peak height are the highest. Therefore, 50 mM PB and 100 mM sodium sulfate are selected as the mobile phase.
[0049] Table 1 Cap peak area and main peak height of porcine circovirus under different mobile phases
[0050] Mobile phase grouping Mobile phase composition Area (mV·s) Main peak height (mV) 1 <![CDATA[50mM Na 2 SO 4 ]]> 22107 217 2 <![CDATA[100mM Na 2 SO 4 ]]> 23781 213 3 <![CDATA[200mM Na 2 SO 4 ]]> 24303 232 4 50mM PB 24088 240 5 <![CDATA[50mM PB+50mM Na 2 SO 4 ]]> 23366 263 6 <![CDATA[50mM PB+100mM Na 2 SO 4 ]]> 24859 270 7 <![CDATA[50mM PB+200mM Na 2 SO 4 ]]> 22463 228 8 100mM PB 23576 245 9 <![CDATA[100mM PB+50mM Na 2 SO 4 ]]> 22854 249 10 <![CDATA[100mM PB+100mM Na 2 SO 4 ]]> 22535 234 11 <![CDATA[100mM PB+200mM Na 2 SO 4 ]]> 22008 221 12 200mM PB 22428 230 13 <![CDATA[200mM PB+50mM Na 2 SO 4 ]]> 22270 227 14 <![CDATA[200mM PB+100mM Na 2 SO 4 ]]> 21869 219 15 <![CDATA[200mM PB+200mM Na 2 SO 4 ]]> 21374 212
[0051] Example 3: Establishment of a quantitative standard curve for porcine circovirus Cap protein.
[0052] A standard of porcine circovirus type 2 Cap protein expressed by recombinant baculovirus was prepared, and the concentration of the standard was determined using the BCA method. The reference sample in Example 1 was diluted with a mobile phase to a standard solution with concentrations of 2800 μg / mL, 1400 μg / mL, 700 μg / mL, 350 μg / mL, and 175 μg / mL.
[0053] All specific absorption peak areas of porcine circovirus Cap protein in the standard solution were determined using the method of Example 1, 10 μL of sample was taken for detection, the detection wavelength was 280 nm, and the flow rate was 0.6 ml / min. All specific absorption peak areas of Cap protein were counted, and each group was repeated 3 times. The results are shown in Table 2.
[0054] Table 2: Test results of porcine circovirus Cap protein standard solution
[0055]
[0056] The standard curve regression equation was established with the standard protein concentration as the ordinate (y) and the peak area as the abscissa (x). The results are as follows: Figure 4 As shown, the linear relationship is y = 0.1136x-22.917, R 2 The specific absorption peak area of porcine circovirus Cap protein and protein concentration have a good linear relationship, and the present invention can be used to accurately quantify the content of porcine circovirus Cap protein. In addition, each concentration of Cap protein standard solution was measured three times in parallel, and the RSD was less than 1%, which proved that the method has good repeatability.
[0057] Example 4: Detection of four porcine circovirus Cap protein subunit vaccine products
[0058] Four porcine circovirus Cap protein subunit vaccine products purchased from the market were tested. The vaccine was first demulsified with n-pentanol, 1 ml of n-pentanol was added to 9 ml of the vaccine, and the mixture was shaken and mixed for two minutes. After standing and stratification, the lower layer of the clear liquid was taken and tested using the method in Example 1 to obtain the VLP peak, monomer peak and total peak area. The concentration of porcine circovirus Cap protein in the four vaccines was calculated according to the linear regression equation obtained in Example 2.
[0059] The results are shown in Table 3 and Figure 5As shown, four porcine circovirus vaccines all detected VLP peaks and monomer peaks, but the VLP assembly rate of each vaccine was different. Vaccines A, B, and C are Cap protein subunit vaccines expressed by eukaryotic systems, and D is a Cap protein subunit vaccine expressed by prokaryotic Escherichia coli. The VLP assembly rate of Cap protein expressed by eukaryotic systems is significantly higher than that of Cap protein expressed by prokaryotic systems. In addition, the VLP assembly rates of Cap protein expressed by eukaryotic systems of different manufacturers are also different. The method of the present invention can not only accurately quantify the content of porcine circovirus Cap protein, but also detect the assembly rate and content of VLP form. The inspection method has the advantages of being fast, accurate, and efficient, and can be used for the quality evaluation of finished vaccines.
[0060] Table 3: Test results of four porcine circovirus Cap protein subunit vaccine products
[0061]
Claims
1. A method for detecting the assembly rate and content of porcine circovirus Cap protein VLP, characterized in that: The high performance liquid size exclusion chromatography detection method was used, and the chromatographic conditions included: Chromatographic column: TSK-gel G6000PWXL; Detection wavelength: 280nm; Mobile phase: The mobile phase composition is 50 mM phosphate buffer and 100 mM sodium sulfate, pH 7.0-7.
2.
2. The method according to claim 1, characterized in that The steps include: (1) Establishing a high performance liquid phase size exclusion chromatography detection method, determining the detection conditions, and obtaining the target porcine circovirus Cap protein VLP chromatographic peak area and porcine circovirus Cap protein monomer peak area in the reference product through the detection method; (2) Establish a standard curve of the linear relationship between the specific absorption peak area of porcine circovirus Cap protein and protein concentration; (3) Detecting the sample by the high performance liquid phase size exclusion chromatography method of step (1), obtaining the specific absorption peak area of the porcine circovirus Cap protein VLP form and the porcine circovirus Cap protein monomer absorption peak area of the sample, substituting the sum of the two absorption peak areas, i.e., the specific absorption peak area of the porcine circovirus Cap protein, into the standard curve of step (2), and calculating the total concentration of the porcine circovirus Cap protein of the sample; (4) Calculate the VLP assembly rate by the ratio of the peak area of the porcine circovirus Cap protein VLP obtained in step (3) to the total peak area of the Cap protein, and calculate the VLP content by multiplying the total Cap protein concentration by the VLP assembly rate.
3. The method according to claim 2, characterized in that In the step (1), a mobile phase was used to balance the baseline before sample injection, the mobile phase flow rate was 0.6 ml / min, the sample injection volume was 10 μL, the detector was an ultraviolet detector, the detection wavelength was 280 nm, the column temperature was 25° C., and the recording time was 30 min.
4. The method according to claim 2, characterized in that: The detection method in step (1) further comprises collecting the main peak and the secondary peak using a fraction collector, and concentrating the collected samples using a 10KDa ultrafiltration concentrator.
5. The method according to claim 4, characterized in that The detection method in step (1) also includes using western blot and electron microscopy methods to identify the samples collected and concentrated in step (1).
6. The method according to claim 1, characterized in that In the high performance liquid size exclusion chromatography detection method used in the steps (1), (2), (3) and (4), the chromatographic column used is TSK-gel G6000PWXL; in the high performance liquid size exclusion chromatography method in the steps (1), (2), (3) and (4), the mobile phase needs to be filtered through a filter with a pore size of 0.22 μm and ultrasonically treated before use.
7. The method according to claim 1, characterized in that In the step (2), a linear regression equation is established with the standard protein concentration as the ordinate and the peak area as the abscissa. The linear relationship is y=0.1136x-22.917, and its R 2 is 0.9998.
8. The method according to claim 1, characterized in that In the linear regression equation range of the porcine circovirus Cap protein, the concentration is 175 μg / mL to 2800 μg / mL.
